(en) Peter Horby, Wei Shen Lim, Jonathan Emberson et Marion Mafham, « EDexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report », New England Journal of Medicine, Infectious Diseases (except HIV/AIDS), (DOI10.1056/NEJMoa2021436, lire en ligne, consulté le ).
(en) The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Jonathan A. C. Sterne, Srinivas Murthy et Janet V. Diaz, « Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis », JAMA, (ISSN0098-7484, DOI10.1001/jama.2020.17023, lire en ligne, consulté le ).
(en) The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Jonathan A. C. Sterne, Srinivas Murthy et Janet V. Diaz, « Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis », JAMA, (ISSN0098-7484, DOI10.1001/jama.2020.17023, lire en ligne, consulté le ).
jamanetwork.com
(en) The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Jonathan A. C. Sterne, Srinivas Murthy et Janet V. Diaz, « Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis », JAMA, (ISSN0098-7484, DOI10.1001/jama.2020.17023, lire en ligne, consulté le ).
lejournaldumedecin.com
Luc Ruidant, « Covid-19 : efficacité confirmée des corticostéroïdes pour les formes graves », Le journal du médecin, (lire en ligne, consulté le ).
(en) Peter Horby, Wei Shen Lim, Jonathan Emberson et Marion Mafham, « EDexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report », New England Journal of Medicine, Infectious Diseases (except HIV/AIDS), (DOI10.1056/NEJMoa2021436, lire en ligne, consulté le ).
